FIELD: medicine.
SUBSTANCE: there are described new compounds of general formula 
where Xa represents 2 to 4 condensed cycloalkyl, aryl, heterocyclic rings containing 1 to 2 heteroatoms, chosen of N and O, and heteroaryl rings containing 1 to 4 heteroatoms, chosen of N, O or S where said rings can be additionally substituted. (Radical values R1-R4, R1, Y and n are specified in the patent claim), specific representatives of said compounds and a pharmaceutical composition containing them.
EFFECT: new compounds are effective in stimulation of endogenous development or release of growth hormone and can be used in treating obesity, osteoporosis and for increasing muscle bulk and muscle strength.
17 cl, 339 ex, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING CYCLOPROPANE DERIVATIVES | 2011 |
|
RU2593202C2 |
| NEW 5,6-DIHYDROPYRIDINE-2-ON COMPOUNDS APPLICABLE AS THROMBIN INHIBITORS | 2004 |
|
RU2335492C2 |
| SPIROOXYINDOLE DERIVATIVES AND APPLICATION THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2415143C2 |
| BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773346C2 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AS FGFR INHIBITORS | 2007 |
|
RU2466130C2 |
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
| CASPASE INHIBITOR PRODRUGS | 2006 |
|
RU2427582C2 |
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
| BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, OBTAINING THEM AND THEIR USE | 2004 |
|
RU2329254C2 |
| IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
